Antiviral Therapy

From Wikipedia, the free encyclopedia

This article is about the biomedical journal. For therapy with antiviral agents, see antiviral drug.

Antiviral Therapy

Abbreviated title	Antivir Ther, AVT
Discipline	Antivirals
Language	English
Publication details
Publisher	International Medical Press (UK)
Publication history	founded 1996
Frequency	8 per year
Open access	after 12 months
Impact factor	4.982 (2006)
Indexing
ISSN	1359-6535
Links
Journal homepage

Antiviral Therapy is a peer-reviewed academic journal published by International Medical Press, London, UK (a subsidiary of MediTech Media). It publishes primary papers and reviews on all aspects of the clinical development of antivirals, including clinical trial results, resistance, viral diagnostics, drug safety, pharmacoepidemiology and vaccines. Antiviral Therapy is an official publication of the International Society for Antiviral Research.

The journal was founded in 1996 by Douglas D. Richman (University of California, San Diego, La Jolla, USA) and Joep M.A. Lange (University of Amsterdam, The Netherlands), who serve as the Editors-in-Chief as of 2007. The early issues were published by MediTech Media Ltd. The initial publication frequency was quarterly, rising to bimonthly in 2003 and to eight issues a year in 2005. The journal also publishes supplements containing abstracts from various conferences and workshops, including the International HIV Drug Resistance Workshop, International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV and Therapies for Viral Hepatitis Workshop.

Articles from 1998 are archived online in PDF format, with content over a year old being free. All online content is available free to those living in developing countries.

The journal had an impact factor of 4.982 in 2006, placing it fourth of 23 journals in the virology category.^[1] It is indexed by Chemical Abstracts, Current Contents (Clinical Medicine), EMBASE/Excerpta Medica, Medline/Index Medicus, Research Alert and SciSearch.